A slowdown in China has hit its financial markets hard this year as fund managers cut exposure to the world's second largest economy, but some investors say it may be time to jump back in.
China has a drug problem. While most Western countries spend 10-12 percent of their health care budget on medicines, in China it is well over 40 percent, a disparity that goes to the heart of Beijing's crackdown on the industry.
Qatar may tone down its pushy foreign policy, chastened by setbacks in Syria and Egypt, but is likely to keep supporting Arab Spring revolts and bankrolling Islamist influence, albeit a little more quietly.
Another dramatic showdown between Republicans and the White House over federal spending looks inevitable this fall, with scary talk of government shutdowns and default on government debt.
Detroit officials hope the bruising bankruptcy battle ahead of them will be rewarded with the birth of a leaner, more efficient and ultimately prosperous Motown.
Like the coming of the messiah, depressed southern Europe nations await Angela Merkel's likely victory in Germany's September election with a mixture of hope and trepidation.
What if German savers were to help rescue Greece, Portugal or Spain by investing in their state assets and companies rather than bailing them out with taxpayer-backed loans?
When Gina McCarthy steps into her new role as administrator of the U.S. Environmental Protection Agency she will face an army of lawyers trying to sway the agency as it writes rules on power-plant emissions that will form the centerpiece of the Obama administration's climate-action plan.
The success or failure of China's efforts to revamp its giant economy may rest with workers like Hu Zhao and Deng Jindong.
Liz Cheney's decision to challenge Wyoming U.S. Senator Mike Enzi in a Republican primary next year sets up the type of divisive, intraparty fight that Republican leaders vowed to avoid after the 2012 elections.